XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
9 Months Ended
Sep. 30, 2022
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS  
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

5. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

The Company’s cash equivalents and short-term investments are invested in the following (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

September 30, 2022

​

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

​

$

52,029

​

$

—

​

$

—

​

$

52,029

Total cash equivalents

​

​

52,029

​

​

—

​

​

—

​

​

52,029

Commercial paper

​

​

71,888

​

​

—

​

​

—

​

​

71,888

Corporate bonds

​

​

29,020

​

​

—

​

​

(213)

​

​

28,807

U.S. Treasury securities

​

​

29,797

​

​

—

​

​

(110)

​

​

29,687

Government bonds

​

​

14,798

​

​

—

​

​

(137)

​

​

14,661

Asset-backed securities

​

​

3,984

​

​

—

​

​

(6)

​

​

3,978

Total short-term investments

​

​

149,487

​

​

—

​

​

(466)

​

​

149,021

Total cash equivalents and short-term investments

​

$

201,516

​

$

—

​

$

(466)

​

$

201,050

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

December 31, 2021

​

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

​

$

46,521

​

$

—

​

$

—

​

$

46,521

Total cash equivalents

​

​

46,521

​

​

—

​

​

—

​

​

46,521

Commercial paper

​

​

70,401

​

​

—

​

​

—

​

​

70,401

Corporate bonds

​

​

65,645

​

​

—

​

​

(28)

​

​

65,617

Government bonds

​

​

36,487

​

​

—

​

​

(11)

​

​

36,476

Asset-backed securities

​

​

24,665

​

​

—

​

​

(10)

​

​

24,655

Total short-term investments

​

​

197,198

​

​

—

​

​

(49)

​

​

197,149

Total cash equivalents and short-term investments

​

$

243,719

​

$

—

​

$

(49)

​

$

243,670

​

During the year ended December 31, 2021, the Company made a $20.0 million investment in equity securities of a publicly-traded company. The Company records this investment at fair value, which was $1.2 million as of September 30, 2022. Prior to the investment, the Company entered into a subscription agreement to purchase the investment, resulting in a subscription agreement liability which was derecognized upon investment. During the three and nine months ended September 30, 2022, the Company recorded an unrealized loss due to the change in fair value of the equity securities of $0.3 million and $6.2 million, respectively, in interest and other (expense) income, net in the consolidated statements of operations.